Basics Pliant Therapeutics, Inc. IPO Date: June 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $88.4M Activated in VL: True Average Daily Range Avg Daily Range: $0.57 | 3.16% Avg Daily Range (30 D): $0.05 | 3.10% Avg Daily Range (90 D): $0.16 | 4.76% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): .76M Avg Daily Volume (90 D): 1.8M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 167 Avg Trade Size (Sh.) (90 D): 195 Institutional Trades Total Inst.Trades: 1,072 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $1.96M Avg Inst. Trade (90 D): $1.55M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $2.04M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 91.78K     News Mar 23, 2025 @ 12:34 PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates ... Source: N/A Feb 7, 2025 @ 9:58 PM Pliant Therapeutics Provides Update on BEACON-IPF,... Source: N/A Nov 18, 2024 @ 11:00 PM Pliant Therapeutics Presents Data from its Bexoteg... Source: N/A Jul 13, 2024 @ 1:35 AM Pliant Therapeutics CBO sells shares worth over $1... Source: Investing.Com May 7, 2024 @ 3:53 PM These Analysts Revise Their Forecasts On Pliant Th... Source: Avi Kapoor Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.92 $-.95 Diluted EPS $-.92 $-.95 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -56.17M $ -57.76M Operating Income / Loss $ $ -58.94M $ -62.01M Cost of Revenue $ $ $ Net Cash Flow $ $ 20.75M $ -.77M PE Ratio